MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/03007995.2016.1218838

Медицинская библиотека · Current medical research and opinion · 2016

Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.

Robles Nicolas Roberto, Calvo Carlos, Sobrino Javier, Espinel Eugenia, Esteban Rafael, Mateos Lourdes, Macias Juan F

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

The RED LEVEL study (REnal Disease: LErcanidipine Valuable Effect on urine protein Losses) directly compares, in an explorative fashion, the effects of lercanidipine + enalapril and amlodipine + enalapril combinations on renal parameters in hypertensive subjects.

RESEARCH DESIGN AND

METHODS

This was a 1 year, prospective, multi-center, randomized, open-label, blinded-endpoint (PROBE) study in hypertensive patients with albuminuria.

MAIN OUTCOME MEASURES: Renal function (albuminuria, serum creatinine, creatinine clearance, estimated glomerular filtration rate and proteinuria); blood pressure.

RESULTS

Albuminuria was significantly reduced, compared with baseline values, with the lercanidipine + enalapril combination over the entire study period; at month 3, month 6 and month 12, changes from baseline were: -162.5 (p-value = 0.0439), -425.8 (p-value = 0.0010), -329.0 (p-value = 0.0011) mg/24 h), respectively. On the other hand, this improvement was not observed with enalapril + amlodipine. Other parameters of renal function such as serum creatinine, creatinine clearance, estimated glomerular filtration rate and proteinuria did not change over the study. Both lercanidipine + enalapril and amlodipine + enalapril significantly reduced systolic and diastolic blood pressure values from baseline all over the study period with no significant differences between groups. Safety outcomes were comparable between the two groups.

CONCLUSIONS

Overall, the results of this explorative study lend support to the anti-albuminuric effect of the lercanidipine + enalapril combination and to the long term renal-protective effects of this combination in patients with hypertension.

Для цитирования: Robles Nicolas Roberto, Calvo Carlos, Sobrino Javier, Espinel Eugenia, Esteban Rafael, Mateos Lourdes, Macias Juan F. Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.. Current medical research and opinion. 2016. DOI: 10.1080/03007995.2016.1218838.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.